Ordering
Available Variants10 mg
CHA.74528-10mg
Price
€248.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.74528-10mg | €248.80 |
≥99% (TLC), powder, ionotropic glutamate receptor (kainate class) agonist
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C10H15NO4 · H2O |
|---|---|
| CAS Number | 58002-62-3 |
| Molecular Weight | 231.25 |
| UNSPSC Code | 12352106 |
| PubChem Substance ID | 24277985 |
| NACRES | NA.77 |
| MDL number | MFCD00150833 |
| Assay | ≥99% (TLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Kainic acid monohydrate, with the chemical formula C10H15NO4S and CAS number 487-79-6, is a naturally occurring amino acid derivative that has been extensively studied for its neuroexcitatory properties. It is a potent agonist of the AMPA and kainate receptors, which are subclasses of glutamate receptors that play crucial roles in excitatory neurotransmission. Kainic acid monohydrate has been used as a research tool to investigate the mechanisms of excitotoxicity, neurodegeneration, and synaptic plasticity. Its ability to induce seizures and neurodegeneration has also made it a valuable model compound for the study of neurological disorders, including epilepsy and neurodegenerative diseases. The monohydrate form of kainic acid is commonly used in laboratory settings due to its increased stability and solubility compared to the anhydrous form.
